Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy
- PMID: 2224844
Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy
Abstract
Two isoforms of the regulatory subunits of cyclic AMP (cAMP)-dependent protein kinase that bind cAMP are inversely expressed during ontogeny and cell differentiation. These cAMP-binding receptor proteins in harmony may regulate the growth of normal cells and their differentiation into nondividing states. Cancer cells can also be made to differentiate and stop growing when the functional balance of these cAMP receptor proteins is restored by treatment with site-selective cAMP analogues or by the use of an antisense oligodeoxynucleotide, suggesting new approaches to cancer treatment.
Similar articles
-
Synergistic inhibition of growth of breast and colon human cancer cell lines by site-selective cyclic AMP analogues.Cancer Res. 1988 Mar 15;48(6):1642-50. Cancer Res. 1988. PMID: 2830966
-
An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells.Cancer Res. 1993 Feb 15;53(4):868-72. Cancer Res. 1993. PMID: 8428367
-
Role of site-selective cAMP analogs in the control and reversal of malignancy.Pharmacol Ther. 1991;50(1):1-33. doi: 10.1016/0163-7258(91)90071-s. Pharmacol Ther. 1991. PMID: 1653961 Review.
-
Induction of the regulatory subunit of type I adenosine cyclic 3':5'-monophosphate-dependent protein kinase in differentiated N-18 mouse neuroblastoma cells.Cancer Res. 1981 Nov;41(11 Pt 1):4579-87. Cancer Res. 1981. PMID: 6272981
-
Modulation of adenylate cyclase signalling.Semin Cancer Biol. 1992 Dec;3(6):361-7. Semin Cancer Biol. 1992. PMID: 1286157 Review.
Cited by
-
Upregulated GPRC5A disrupting the Hippo pathway promotes the proliferation and migration of pancreatic cancer cells via the cAMP-CREB axis.Discov Oncol. 2023 Feb 3;14(1):17. doi: 10.1007/s12672-023-00626-1. Discov Oncol. 2023. PMID: 36735162 Free PMC article.
-
Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves".Wiley Interdiscip Rev Syst Biol Med. 2020 Sep;12(5):e1490. doi: 10.1002/wsbm.1490. Epub 2020 Apr 23. Wiley Interdiscip Rev Syst Biol Med. 2020. PMID: 32323924 Free PMC article. Review.
-
The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Oncology Group trial 92-02.Clin Cancer Res. 2009 Sep 1;15(17):5478-84. doi: 10.1158/1078-0432.CCR-08-2704. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706804 Free PMC article. Clinical Trial.
-
Patterns of cyclic AMP binding in normal human breast.Breast Cancer Res Treat. 1994;30(2):153-8. doi: 10.1007/BF00666059. Breast Cancer Res Treat. 1994. PMID: 7949214
-
Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A.Mol Cell Biol. 1993 Jan;13(1):358-66. doi: 10.1128/mcb.13.1.358-366.1993. Mol Cell Biol. 1993. PMID: 7678053 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources